Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marian Ludgate

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Frontiers in Endocrinology|December 13, 2021
Orbital Signaling in Graves' OrbitopathyMohd Shazli Draman, Lei Zhang, Colin Dayan, et al.
Endocrinology|November 16, 2004
Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathyGlynn Baker, Gherardo Mazziotti, Chris von Ruhland, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|September 11, 2003
Early changes in thyroid-stimulating antibody activity following radioiodine therapyAkheel A Syed, Carol Evans, Marian Ludgate, et al.
Genomics|November 2, 2010
Effect of iodine on early stage thyroid autonomyKathrin Müller, Knut Krohn, Markus Eszlinger, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 13, 2007
Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogsIrina Cozma, Lei Zhang, James Uddin, et al.
Frontiers in Endocrinology|May 16, 2022
Editorial: Mechanisms and Novel Therapies in Graves' Orbitopathy: Current UpdateHuifang Zhou, Ilaria Muller, Kelvin Kam-Lung Chong, et al.
The Journal of Endocrinology|May 23, 2009
Gsalpha signalling suppresses PPARgamma2 generation and inhibits 3T3L1 adipogenesisLei Zhang, Carol Paddon, Mark D Lewis, et al.
Investigative Ophthalmology & Visual Science|November 24, 2006
Biological effects of thyrotropin receptor activation on human orbital preadipocytesLei Zhang, Glynn Baker, Dominika Janus, et al.
The Journal of Endocrinology|September 18, 2009
TSH receptor activation and body compositionAnna de Lloyd, James Bursell, John W Gregory, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use?Kerry Starkey, Armin Heufelder, Glynn Baker, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Frontiers in Endocrinology|December 13, 2021
Orbital Signaling in Graves' OrbitopathyMohd Shazli Draman, Lei Zhang, Colin Dayan, et al.
Endocrinology|November 16, 2004
Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathyGlynn Baker, Gherardo Mazziotti, Chris von Ruhland, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|September 11, 2003
Early changes in thyroid-stimulating antibody activity following radioiodine therapyAkheel A Syed, Carol Evans, Marian Ludgate, et al.
Genomics|November 2, 2010
Effect of iodine on early stage thyroid autonomyKathrin Müller, Knut Krohn, Markus Eszlinger, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 13, 2007
Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogsIrina Cozma, Lei Zhang, James Uddin, et al.
Frontiers in Endocrinology|May 16, 2022
Editorial: Mechanisms and Novel Therapies in Graves' Orbitopathy: Current UpdateHuifang Zhou, Ilaria Muller, Kelvin Kam-Lung Chong, et al.
The Journal of Endocrinology|May 23, 2009
Gsalpha signalling suppresses PPARgamma2 generation and inhibits 3T3L1 adipogenesisLei Zhang, Carol Paddon, Mark D Lewis, et al.
Investigative Ophthalmology & Visual Science|November 24, 2006
Biological effects of thyrotropin receptor activation on human orbital preadipocytesLei Zhang, Glynn Baker, Dominika Janus, et al.
The Journal of Endocrinology|September 18, 2009
TSH receptor activation and body compositionAnna de Lloyd, James Bursell, John W Gregory, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use?Kerry Starkey, Armin Heufelder, Glynn Baker, et al.
Pageof 6